Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 13
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP23F3957 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-05-17 | 2023-05-23 | 325412 | 8509895532!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3956 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-05-17 | 2023-05-23 | 325412 | 8509895468!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3955 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-05-17 | 2023-05-23 | 325412 | 8509895464!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3377 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-04-19 | 2023-04-25 | 325412 | 8509839673!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3374 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-04-19 | 2023-04-25 | 325412 | 8509839557!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3373 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-04-19 | 2023-04-25 | 325412 | 8509839550!ADENOVIRUS TYPE 4 A |
| SPE2DP23F3371 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-04-19 | 2023-04-25 | 325412 | 8509839391!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2844 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-03-22 | 2023-03-28 | 325412 | 8509779033!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2843 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-03-22 | 2023-03-28 | 325412 | 8509778919!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2821 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-03-22 | 2023-03-28 | 325412 | 8509778694!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2820 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-03-22 | 2023-03-28 | 325412 | 8509778640!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2297 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-02-22 | 2023-02-28 | 325412 | 8509714902!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2296 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-02-22 | 2023-02-28 | 325412 | 8509714867!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2294 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-02-22 | 2023-02-28 | 325412 | 8509714738!ADENOVIRUS TYPE 4 A |
| SPE2DP23F2293 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-02-22 | 2023-02-28 | 325412 | 8509714733!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1531 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-01-18 | 2023-01-24 | 325412 | 8509645271!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1530 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-01-18 | 2023-01-24 | 325412 | 8509645248!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1527 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-01-18 | 2023-01-24 | 325412 | 8509645242!ADENOVIRUS TYPE 4 A |
| SPE2DP23F1525 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $305.39K | 2023-01-18 | 2023-01-24 | 325412 | 8509645169!ADENOVIRUS TYPE 4 A |
| SPE2DP23F0892 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-12-06 | 2022-12-20 | 325412 | 8509569705!ADENOVIRUS TYPE 4 A |
| SPE2DP23F0888 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-12-06 | 2022-12-20 | 325412 | 8509568638!ADENOVIRUS TYPE 4 A |
| SPE2DP22F7357 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-09-13 | 2022-09-20 | 325412 | 8509383504!ADENOVIRUS TYPE 4 A |
| SPE2DP22F7355 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-09-13 | 2022-09-20 | 325412 | 8509383501!ADENOVIRUS TYPE 4 A |
| SPE2DP22F7354 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-09-13 | 2022-09-20 | 325412 | 8509383500!ADENOVIRUS TYPE 4 A |
| SPE2DP22F7351 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-09-13 | 2022-09-20 | 325412 | 8509383415!ADENOVIRUS TYPE 4 A |